
- November 2015 Cough, Cold, & Flu
- Volume 81
- Issue 11
Generic Product News (November 2015)
Read about the new generic products featured in November.
Winthrop (a division of Sanofi)
Compare to: Arava (Sanofi)
Indication: Sanofi has announced the availability of Leflunomide Tablets, a generic equivalent to the company’s Arava rheumatoid arthritis (RA) drug, in 10-mg and 20-mg dosage strengths. The product is indicated to treat moderate to severe RA in adults by inhibiting structural damage, as evidenced by x-ray erosions and joint space narrowing, and to improve physical function.
Dosage Forms: Tablets: 10 mg and 20 mg
For More Information: sanofi.com
Calcium Acetate Capsules 667 mgMarketed by: Heritage Pharmaceuticals
Compare to: PhosLo (Fresenius Medical Care)
Indication: Heritage Pharmaceuticals has announced the availability of Calcium Acetate Capsules, the generic equivalent to PhosLo, in a 667-mg dosage strength. The phosphate-binding drug is indicated to reduce serum phosphorus in adult patients with end-stage renal disease.
Dosage Form: Capsules: 667 mg
For More Information: heritagepharma.com
Gemfibrozil Tablets, USPMarketed by: Aurobindo Pharma USA, Inc
Compare to: Lopid (Pfizer)
Indication: Aurobindo Pharma has received FDA approval for Gemfibrozil Tablets, USP, the therapeutic equivalent of Pfizer’s Lopid Tablets, in a 600-mg dosage strength. The product is indicated as an adjunctive therapy to diet for the treatment of adult patients with high elevations of serum triglyceride levels (types IV and V hyperlipidemia). The product also reduces the risk of developing coronary heart disease in type IIb patients only.
Dosage Form: Tablets: 600 mg
For More Information: aurobindo.com
Clopidogrel Tablets, USPMarketed by: Camber Pharmaceuticals
Compare to: Plavix (sanofi-aventis)
Indication: Camber Pharmaceuticals announced the launch of Clopidogrel Tablets, the therapeutic equivalent to sanofi-aventis’s Plavix, in 75-mg dosage strengths in 30-, 90-, and 500- count bottles. The product is indicated for patients with non-ST-segment elevation acute coronary syndrome or patients with a history of recent myocardial infarction, recent stroke, or established peripheral arterial disease.
Dosage Form: Tablets: 75 mg
For More Information: camberpharma.com
Articles in this issue
almost 10 years ago
Child Pain Treatment Decisions Seem to Depend on Racealmost 10 years ago
Placebo Effect Becoming More Powerfulalmost 10 years ago
Tramadol Could Have Serious Side Effects in Childrenalmost 10 years ago
Cholesterol Drugs Lower Stroke Risk in Older Adultsalmost 10 years ago
High Cholesterol Delayed by Elevated Cardiorespiratory Fitnessalmost 10 years ago
High HDL Function Linked to Lower Heart Disease Riskalmost 10 years ago
Colds, Flu May Increase Stroke Risk in Childrenalmost 10 years ago
Cold Symptoms Shortened by Zinc Lozengesalmost 10 years ago
Short Sleepers More Likely to Develop ColdNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































